Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CTCX

Carmell (CTCX) Stock Price, News & Analysis

Carmell logo

About Carmell Stock (NASDAQ:CTCX)

Key Stats

Today's Range
$0.54
$0.54
50-Day Range
$0.44
$0.55
52-Week Range
$0.17
$1.27
Volume
653 shs
Average Volume
4.65 million shs
Market Capitalization
$11.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Receive CTCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carmell and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTCX Stock News Headlines

XAGE Longevity Health Holdings, Inc.
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel
Carmell Therapeutics rebrands to Longevity Health Holdings
Carmell Therapeutics files $100M mixed securities shelf
See More Headlines

CTCX Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Carmell investors own include Sangamo Therapeutics (SGMO), abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), Meta Platforms (META), NVIDIA (NVDA), Blue Owl Capital (OBDC) and Tenax Therapeutics (TENX).

Company Calendar

Today
8/25/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:CTCX
CIK
1842939
Fax
N/A
Employees
14
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
($0.46)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.44 million
Net Margins
N/A
Pretax Margin
-29,527.27%
Return on Equity
-217.50%
Return on Assets
-50.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.31
Quick Ratio
0.29

Sales & Book Value

Annual Sales
$32.84 thousand
Price / Sales
343.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.07 per share
Price / Book
0.50

Miscellaneous

Outstanding Shares
20,905,000
Free Float
14,843,000
Market Cap
$11.27 million
Optionable
Not Optionable
Beta
0.51

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NASDAQ:CTCX) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners